USA Rare Earth (USAR) filed an 8-K on April 20, 2026 announcing a definitive merger with Serra Verde Group, the Brazilian operator of Pela Ema — the only large-scale producer outside Asia of all four magnetic rare earths (Nd, Pr, Dy, Tb). It is the second major US-government-backed critical-minerals deal of the cycle and the first with disclosed floor prices on heavy REEs. It is not, however, structurally identical to MP Materials' Department of War PPA; the differences matter.

What the filing says

• Consideration: $300M cash + 126.85M shares (≈$2.83B equity value; 36.8% dilution). End Date December 31, 2026.
• Serra Verde: producing since 2024, $1.1B+ invested to date. Phase 1 target 6,400 MTPA TREO by end-2027. 25-year mine life.
• Government offtake: 15-year, 100% of Phase 1 production. Guaranteed floor prices for Nd, Pr, Dy, and Tb — floor levels are undisclosed (confidential SPV exhibit). Buyer is an SPV "capitalized by various U.S. Government agencies + private capital sources."
• Financing: DFC $565M package; $435M debt outstanding USAR assumes.
• Board, post-close: Sir Mick Davis (ex-Xstrata CEO) and Thras Moraitis (Serra Verde CEO → USAR President).
• Closing conditions: HSR, USAR stockholder vote at Annual Meeting June 3, DFC/Royalty/Offtake consents, Incremental Loan disbursement.
• What did not change: CHIPS LOI risk language is verbatim identical to the 10-K. Zero binding Stillwater NdFeB magnet contracts. Round Top has no proven reserves; PFS pending.

What the market thinks

USAR closed $22.58 (+13.2% on announcement, 2.2x average volume, RSI 82.5). The stock had already rallied +34.5% the week before — pre-announcement accumulation. Wedbush upgraded day-of to $29; mean analyst target $31.80; five bulls, zero bears. Options flow heavy on the call side (OI P/C 0.47, volume P/C 0.15). MP +8.6% in sympathy, RSI 87.3, +185.6% 1Y.

Related names have also run hard: NioCorp +44.5% 1M, RSI 81.1, +116.9% 1Y (rights plan + Citadel 13G disclosed). US Antimony +30.4% 1M, +254.7% 1Y, RSI 72.1. Largo, the Brazilian vanadium analog, +16.7% 1M, RSI 69.8, -13.6% 1Y. Back-solving the scenario tree against current USAR price implies market P(merger close) ≈ 60%; our read ≈ 65%.

Why a gap may remain — and where it probably doesn't

Two observations worth separating:

The structural finding: The US government has executed two major REE-floor-price deals in nine months. MP (July 2025) is a domestic Department of War PPA at $110/kg NdPr — already cash-producing ($39.2M Q4 2025 Adj EBITDA "primarily due to" the PPA). Serra Verde (April 2026) is an offshore DFC + multi-agency SPV with Dy/Tb floors (levels undisclosed). These are two different channels, not one template — domestic DoW versus offshore DFC+SPV, different buyers, different statutory authorities. What is common is the political commitment to floor-price mechanisms, corroborated by Lynas and Arafura CEOs publicly benchmarking to $110/kg and Australia discussing a strategic reserve.

Where the pricing already caught up: NB and UAMY are RSI 70-80 and multi-hundred-percent 1Y. The "cross-ticker read-through unpriced" framing is only partially right. Market-implied probability of a NioCorp corporate event within six months is plausibly 40-50% already, not 20% — the tape has done most of the work. Largo looks relatively unpriced at $1.33 with negative 1Y return, but that reflects vanadium price weakness and LGO's distressed capital structure, not analyst inattention.

What is genuinely less priced: (i) the pipeline velocity — whether another SPV-with-floor-prices deal lands in the next 6-12 months (Cove Kaz tungsten $700M LOI is the leading candidate; Gécamines copper, TechMet $1B+, URIF $150M are platform capital, not executed SPV offtakes yet); (ii) the level of the Serra Verde Dy/Tb floors — if $400/kg Dy, transformative; if $100/kg, modest. The frame depends on at least one more deal landing on comparable structure. If it doesn't, this becomes a USAR M&A rerate with speculative optionality, not a template.

Risks (ranked)

1. Stockholder vote, June 3. 36.8% dilution is large; vote-passing probability range 75-85%.
2. Gutnick Delaware Supreme Court appeal. USAR dismissed from the appellate action, but the individual fiduciary-duty and fraud allegations against Gutnick and his trust remain open. A 36.8%-dilution transaction is exactly the fact pattern plaintiffs' bar pursues; post-close challenges are plausible.
3. Valuation multiple sensitivity. At 8x 2027 Serra Verde EBITDA midpoint ($600M), per-share Serra Verde contribution ≈ $13 (pre-cash). At 5-6x (more defensible for single-customer SPV-concentrated Brazilian ionic clay), per-share drops to $9-10. The "$17-20 already priced" framing flips to "$13-15 already priced" on the lower multiple.
4. Incremental Loan disbursement. Amount undisclosed; both-parties closing condition. If DFC doesn't disburse, deal dies.
5. Dy/Tb floor levels undisclosed. Single most important input for Serra Verde valuation; confidential per Item 601(b)(2).
6. Execution juggle. Six concurrent transactions: Serra Verde, TMRC/Round Top, Carester, CHIPS LOI, Stillwater ramp, France (LCM Lacq).
7. CHIPS LOI. Still non-binding; $435M new leverage makes the $250M revolver condition harder.
8. Valuation based on management guidance. Combined 2030 $1.8B EBITDA is unaudited forward guidance; pre-revenue base; $4.1B+ remaining capex to deliver.

Catalysts

• ~May 6-15, 2026: MP Q1 earnings. Adj EBITDA >$45M would confirm domestic-PPA cash flow at scale.
• June 3, 2026: USAR Annual Meeting / stockholder vote on merger.
• Q3 2026: Serra Verde target close.
• September 30, 2026: Stillwater first customer contract deadline; NioCorp material 8-K window.
• December 31, 2026: CHIPS LOI → definitive deadline; additional DFC deal plausible but not guaranteed.
• Q1 2027: Round Top PFS.

What would change our mind

• Bullish: Cove Kaz tungsten LOI converts to executed SPV with disclosed floors; Lynas or Arafura signs a US government offtake structure; MP Q1 Adj EBITDA >$50M.
• Bearish: USAR stockholder vote fails OR Incremental Loan disclosed unavailable (deal dies); MP Q1 Adj EBITDA <$35M (template cash-flow thesis wounded); Gutnick adverse Delaware ruling; another 12 months pass with no new SPV-with-floors deal executed (the frame collapses to "two one-offs").

Evidence